US5238688A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for preparing a powdered particulate composition
Assignee: Organon NV
•
Filing: 1990-12-27
•
Granted: 1993-08-24
•
Expires: 2010-12-27
Abstract
Abstract Disclosed are powdered particulates or granules useful for the preparation of certain psychotropic compounds (e.g. mianserin are mirtazepine). The resulting suspensions and relatively tasteless, do not have a local anaesthetic effect and are easy to suspend. The granules contain the psychotropic compound, a cellulose derivative, polymer, and a filler.
Inventors
- 👤 Gerrit B. M. Beuving
- 👤 Henrik de Nijs
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 19:09
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/55; A61K31/435; A61K31/44; A61K31/445; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1635; A61K9/1652; A61P; A61P25/00; A61P25/18
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
181 words
A process of manufacturing a powdered particulate comprising: dissolving (a) 1-5 parts by weight of the free base of a compound of the formula: ##STR2## in which X=carbon or nitrogen, Y=carbon or nitrogen, R 1 and R 2 are each independently selected from H, OH, O-alkyl (1-4 C atoms), alkyl (1-4 C atoms) and a halogen, R 3 =H or alkyl (1-4 C atoms), and the broken line indicates an extra bond that may be present when Y is a carbon atom, (b) 0.3-3 parts by weight of a cellulose derivative that is soluble in water and organic solvents, and (c) 4-20 parts by weight of a water insoluble pharmaceutically acceptable polymer in an organic solvent; and mixing with the solution formed (d) 40-250 parts by weight of a pharmaceutical filler distinct from said cellulose derivative and also distinct from said water insoluble pharmaceutically acceptable polymer and granulating said mixture, wherein the amount of organic solvent used is an amount of solvent effective for dissolving the compound, cellulose derivative and polymer and for granulating the solution formed with the pharmaceutical filler.
Claim 2
Dependent Claim
181 words
A process of manufacturing a powdered particulate comprising: dissolving (a) 1-5 parts by weight of the free base of a compound of the formula: ##STR2## in which X=carbon or nitrogen, Y=carbon or nitrogen, R 1 and R 2 are each independently selected from H, OH, O-alkyl (1-4 C atoms), alkyl (1-4 C atoms) and a halogen, R 3 =H or alkyl (1-4 C atoms), and the broken line indicates an extra bond that may be present when Y is a carbon atom, (b) 0.3-3 parts by weight of a cellulose derivative that is soluble in water and organic solvents, and (c) 4-20 parts by weight of a water insoluble pharmaceutically acceptable polymer in an organic solvent; and mixing with the solution formed (d) 40-250 parts by weight of a pharmaceutical filler distinct from said cellulose derivative and also distinct from said water insoluble pharmaceutically acceptable polymer and granulating said mixture, wherein the amount of organic solvent used is an amount of solvent effective for dissolving the compound, cellulose derivative and polymer and for granulating the solution formed with the pharmaceutical filler.
Claim 3
Dependent Claim
25 words
A process of manufacturing according to claim 1 further comprising screening the granules obtained to select a particle size of between 100 and 300 μm.
Claim 4
Dependent Claim
25 words
A process of manufacturing according to claim 1 further comprising screening the granules obtained to select a particle size of between 50 and 500 μm.
Claim 5
Dependent Claim
24 words
The process of manufacturing according to claim 1, wherein an acrylate polymer insoluble in water is used as the water insoluble pharmaceutically acceptable polymer.
Claim 6
Dependent Claim
14 words
The process of manufacturing according to claim 1, wherein the cellulose derivative is hydroxypropylcellulose.
Claim 7
Dependent Claim
15 words
The process of manufacturing according to claim 1, wherein mannitol is used as the filler.
Claim 8
Dependent Claim
61 words
The process of manufacturing according to claim 1, wherein the resulting powdered particulate comprises: a) 2-3 parts by weight of said free base, b) 8-15 parts by weight of an acrylic resin, comprising copolymers of acrylic and methacrylic acid esters, that is slightly permeable to water, c) 0.8-1.2 parts by weight of hydroxypropylcellulose, and d) 80-150 parts by weight of mannitol.
Claim 9
Dependent Claim
14 words
The process of manufacturing according to claim 1, wherein the free base is mianserin.
References Cited (Backward Citations)
US4128641A
Cited
US4284559A
Cited
US4447437A
Cited
US4623588A
Cited
US4870060A
Cited
US4801460A
Cited
US4834985A
Cited
US4938967A
Cited
EP0320097A1
Cited
EP0319061A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-08-23 | 1997-02-22 | 1997-08-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-08-23 | 2001-02-22 | 2001-08-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-08-23 | 2005-02-22 | 2005-08-24 | $7700.00 | Window Closed / Lapsed |